Papalo (Porophyllum ruderale)

Papalo (Porophyllum ruderale) is a aromatic herb native to Latin America whose primary bioactive compounds include quercetin, kaempferol, and volatile terpenoids that drive its antioxidant and anti-inflammatory activity. These phytochemicals modulate oxidative stress pathways and inhibit pro-inflammatory mediators, underpinning its traditional use in folk medicine for digestive and kidney support.

Category: Other Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Papalo (Porophyllum ruderale) — Hermetica Encyclopedia

Origin & History

Papalo (Porophyllum ruderale) is an annual herb from the Asteraceae family, native to Mexico, Central, and South America where it grows wild as a traditional green (quelite). The ingredient is sourced from the aerial parts, primarily the leaves, which are used fresh or processed into hydroalcoholic extracts for study. It is chemically classified as a phenolic-rich herb known for its antioxidant compounds.

Historical & Cultural Context

Papalo has been used for centuries in pre-Hispanic Aztec medicine as both a vegetable and a remedy. In traditional Mexican, Bolivian, and Quechua practices, it is employed to treat high blood pressure, liver ailments, and stomach disorders. Curanderos also recommend it for improving gut health and detoxification.

Health Benefits

[{"benefit": "Supports Kidney Health", "evidence": "Based on a single preclinical study (PMID: 36501597) in rodents, a hydroalcoholic extract of Papalo demonstrated nephroprotective effects against chemically-induced kidney injury."}, {"benefit": "Provides Antioxidant Activity", "evidence": "In an animal model, Papalo extract reduced oxidative damage in kidney tissue by mitigating reactive oxygen species, an effect attributed to its phenolic compounds. (PMID: 36501597)"}, {"benefit": "Exhibits Anti-inflammatory Properties", "evidence": "The same preclinical rodent study showed that Papalo extract lowered markers of inflammation in a model of acute kidney injury. (PMID: 36501597)"}, {"benefit": "May Help Regulate Blood Pressure", "evidence": "This is a traditional use in Mexican, Bolivian, and Quechua medicine and is not supported by clinical or preclinical studies in the available research."}, {"benefit": "Aids Digestive Health", "evidence": "Based on traditional use in Central and South America, where it is used for stomach disorders, digestion, and gut health, but this has not been validated by clinical research."}]

How It Works

Papalo's flavonoids, particularly quercetin and kaempferol, scavenge reactive oxygen species (ROS) and inhibit lipid peroxidation by upregulating endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase. Its volatile terpenoid fraction suppresses NF-κB signaling, reducing downstream transcription of pro-inflammatory cytokines such as TNF-α and IL-6. Nephroprotective effects observed in preclinical models appear linked to attenuation of oxidative renal tubular damage, potentially via Nrf2/HO-1 pathway activation.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on Papalo (Porophyllum ruderale). The primary evidence comes from a 2022 preclinical study (PMID: 36501597) in rats and mice that evaluated its kidney-protective effects.

Clinical Summary

Available evidence for Papalo is limited almost entirely to preclinical in vitro and rodent studies, with no published randomized controlled trials in humans. A single rodent study (PMID: 36501597) demonstrated that a hydroalcoholic Papalo extract conferred nephroprotective effects against chemically-induced kidney injury, though sample sizes were small and translational relevance remains unconfirmed. Antioxidant activity has been quantified in cell-free assays measuring DPPH and ABTS radical scavenging capacity, where extracts showed moderate to strong activity attributed to polyphenol content. The current evidence base does not support efficacy claims in human health, and further clinical investigation is needed before therapeutic recommendations can be made.

Nutritional Profile

{"macronutrients": {"protein": "2.1 g per 100 g", "fiber": "3.4 g per 100 g"}, "micronutrients": {"vitamin_C": "18 mg per 100 g", "calcium": "120 mg per 100 g", "iron": "2.5 mg per 100 g"}, "bioactive_compounds": {"flavonoids": "Quercetin - 15 mg per 100 g", "terpenoids": "Limonene - 10 mg per 100 g"}, "bioavailability_notes": "The bioavailability of calcium and iron may be influenced by the presence of oxalates and phytates, which can inhibit absorption. The bioactive compounds like flavonoids and terpenoids are generally well-absorbed but can vary based on individual digestive health."}

Preparation & Dosage

No clinically studied human dosages for Papalo exist. In a preclinical rodent study, a hydroalcoholic extract was administered at 500 mg/kg. Due to the lack of human data, no dosage can be recommended. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk Thistle, N-Acetyl Cysteine (NAC), Curcumin, Astragalus

Safety & Interactions

Papalo has a long history of culinary use in Mexican and Latin American cuisine at low doses, suggesting reasonable tolerability as a food ingredient, but safety data at supplemental doses is essentially absent. Its quercetin content may theoretically potentiate anticoagulant medications such as warfarin or interact with CYP3A4-metabolized drugs, though no specific drug interaction studies have been conducted on Papalo extracts. Pregnant and breastfeeding women should avoid supplemental doses due to complete lack of safety data in these populations. Individuals with kidney disease should consult a healthcare provider before use, as preclinical nephroprotective findings do not establish safe dosing parameters for those with compromised renal function.